Author:
Kinon Bruce J.,Zhang Lu,Millen Brian A.,Osuntokun Olawale O.,Williams Judy E.,Kollack-Walker Sara,Jackson Kimberley,Kryzhanovskaya Ludmila,Jarkova Natalia
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference14 articles.
1. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo3.1.0-hexane-4,6-dicarboxylic acid (LY404039).;Rorick-Kehn;J Pharmacol Exp Ther,2007
2. Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?;Schoepp;Curr Drug Targets CNS Neurol Disord,2002
3. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial.;Patil;Nat Med,2007
4. The brief psychiatric rating scale.;Overall;Psychol Rep,1962
5. The positive and negative syndrome scale (PANSS) for schizophrenia.;Kay;Schizophr Bull,1987
Cited by
226 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献